Janina Marißen

Efficacy of <i>Bifidobacterium animalis</i> subsp. lactis (BB-12), <i>B. infantis</i> and <i>Lactobacillus acidophilus</i> (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study Protocol

Janina Marißen, Annette Haiß, Claudius U. Meyer et al. · BMJ Open · 2019 · 33 citations · Full text

Meconium Microbiome of Very Preterm Infants across Germany

Jonas Klopp, Pamela Ferretti, Claudius U. Meyer et al. · mSphere · 2022 · 29 citations · Full text

Lactobacillus Acidophilus/Bifidobacterium Infantis Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human Milk

Mats Ingmar Fortmann, Janina Marißen, Bastian Siller et al. · Nutrients · 2020 · 25 citations · Full text

<i>Bifidobacterium</i> and <i>Lactobacillus</i> Probiotics and Gut Dysbiosis in Preterm Infants

Thea Van Rossum, Annette Haiß, Rebecca L. Knoll et al. · JAMA Pediatrics · 2024 · 25 citations · Full text

Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine Vaccinations

Mats Ingmar Fortmann, Marie-Theres Dammann, Alexander Humberg et al. · Vaccines · 2021 · 14 citations · Full text